{"date":"2025-10-16","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-10-16-2011-y9khmy","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-10-16","time":"20:11:23","subject":"代重要子公司Belite Bio, Inc公告受邀參加Maxim Group投資銀行舉辦之成長高峰會(Maxim Growth Summit)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-10-16 20:11，「代重要子公司Belite Bio, Inc公告受邀參加Maxim Group投資銀行舉辦之成長高峰會(Maxim Gro」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-10-16-1800-18ru1bv","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-10-16","time":"18:00:05","subject":"公告本公司與永裕公司間民事訴訟案第三審判決結果","clause":"第2款","fact_date":"2025-10-16","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-10-16 18:00，「公告本公司與永裕公司間民事訴訟案第三審判決結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-10-16-1735-vhrt8q","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-10-16","time":"17:35:40","subject":"公告本公司接獲美國FDA Type C meeting之會議紀錄","clause":"第8款","fact_date":"2025-10-16","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-10-16 17:35，「公告本公司接獲美國FDA Type C meeting之會議紀錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2025-10-16-1716-dxd1z6","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2025-10-16","time":"17:16:09","subject":"更正公告本公司114年9月份自結合併損益","clause":"第53款","fact_date":"2025-10-16","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2025-10-16 17:16，「更正公告本公司114年9月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-10-16-1710-1m82fk","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-10-16","time":"17:10:39","subject":"公告本公司撤銷114年第一次現金增資發行新股案","clause":"第9款","fact_date":"2025-10-16","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-10-16 17:10，「公告本公司撤銷114年第一次現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-10-16-1658-13fa9jr","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-10-16","time":"16:58:41","subject":"本公司參加統一證券國際法人部所舉辦之法人說明會，說明產業及本公司營運概況。","clause":"第12款","fact_date":"2025-10-21","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-10-16 16:58，「本公司參加統一證券國際法人部所舉辦之法人說明會，說明產業及本公司營運概況。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-10-16-1649-gi3647","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-10-16","time":"16:49:09","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第41款","fact_date":"2025-10-16","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-10-16 16:49，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-10-16-1629-1bznhfh","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-10-16","time":"16:29:31","subject":"公告本公司國內第一次無擔保轉換公司債收足應募價款","clause":"第53款","fact_date":"2025-10-16","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-10-16 16:29，「公告本公司國內第一次無擔保轉換公司債收足應募價款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-10-16-1521-1li9q3l","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-10-16","time":"15:21:01","subject":"代本公司重要子公司葡眾企業股份有限公司補充說明114/10/08資安事件","clause":"第26款","fact_date":"2025-10-16","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-10-16 15:21，「代本公司重要子公司葡眾企業股份有限公司補充說明114/10/08資安事件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}